BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6106099)

  • 1. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report.
    Addiego JE; Ammann AJ; Schiffman G; Baehner R; Higgins G; Hammond D
    Lancet; 1980 Aug; 2(8192):450-2. PubMed ID: 6106099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to pneumococcal vaccine among children with Hodgkin's disease.
    Donaldson SS; Vosti KL; Berberich FR; Cox RS; Kaplan HS; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S133-43. PubMed ID: 6895119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease.
    Frederiksen B; Specht L; Henrichsen J; Pedersen FK; Pedersen-Bjergaard J
    Eur J Haematol; 1989 Jul; 43(1):45-9. PubMed ID: 2767242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children.
    Pedersen FK; Henrichsen J; Schiffman G
    Acta Paediatr Scand; 1982 May; 71(3):451-5. PubMed ID: 7136661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine.
    Ammann AJ; Schiffman G; Addiego JE; Wara WM; Wara DW
    Rev Infect Dis; 1981; 3 Suppl():S160-7. PubMed ID: 7280446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease.
    Chan CY; Molrine DC; George S; Tarbell NJ; Mauch P; Diller L; Shamberger RC; Phillips NR; Goorin A; Ambrosino DM
    J Infect Dis; 1996 Jan; 173(1):256-8. PubMed ID: 8537671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal vaccine failures. Two case reports and review.
    Sumaya CV; Harbison RW; Britton HA
    Am J Dis Child; 1981 Feb; 135(2):155-8. PubMed ID: 7468549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.
    Siber GR; Gorham C; Martin P; Corkery JC; Schiffman G
    Ann Intern Med; 1986 Apr; 104(4):467-75. PubMed ID: 3082268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of pneumococcal polysaccharide vaccine in children.
    Obaro S; Leach A; McAdam KW
    Lancet; 1998 Aug; 352(9127):575. PubMed ID: 9716086
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of patients with Hodgkin's disease to pneumococcal vaccine.
    Minor DR; Schiffman G; McIntosh LS
    Ann Intern Med; 1979 Jun; 90(6):887-92. PubMed ID: 36021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
    Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
    Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
    Siber GR; Weitzman SA; Aisenberg AC
    Rev Infect Dis; 1981; 3 Suppl():S144-59. PubMed ID: 7280445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.
    Petrasch S; Kühnemund O; Reinacher A; Uppenkamp M; Reinert R; Schmiegel W; Lütticken R; Brittinger G
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):635-8. PubMed ID: 9384280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine.
    Hosea SW; Burch CG; Brown EJ; Berg RA; Frank MM
    Lancet; 1981 Apr; 1(8224):804-7. PubMed ID: 6111673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
    Siber GR; Weitzman SA; Aisenberg AC; Weinstein HJ; Schiffman G
    N Engl J Med; 1978 Aug; 299(9):442-8. PubMed ID: 28483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
    Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
    Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
    Landesman SH; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides.
    Giebink GS; Le CT; Schiffman G
    J Pediatr; 1984 Oct; 105(4):576-82. PubMed ID: 6481533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.